DNA-methylome-derived epigenetic fingerprint as an immunophenotype indicator of durable clinical immunotherapeutic benefits in head and neck squamous cell carcinoma.
Saved in:
| Title: | DNA-methylome-derived epigenetic fingerprint as an immunophenotype indicator of durable clinical immunotherapeutic benefits in head and neck squamous cell carcinoma. |
|---|---|
| Authors: | Li, Rui1 (AUTHOR), Wen, Xin1 (AUTHOR), Lv, Ru-xue1 (AUTHOR), Ren, Xian-yue2 (AUTHOR), Cheng, Bing-lin1 (AUTHOR), Wang, Yi-kai1 (AUTHOR), Chen, Ru-zhen1 (AUTHOR), Hu, Wen1 (AUTHOR), Tang, Xin-Ran1 (AUTHOR) tangxran@163.com |
| Source: | Cellular Oncology (2211-3428). Aug2024, Vol. 47 Issue 4, p1129-1148. 20p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 22113428 |
|---|---|
| DOI: | 10.1007/s13402-024-00917-x |
